arXiv Science⌕ Search

arXiv · 2609.25040

BananaVLM: A Domain-Adapted Vision Language Model for Banana Crop Disease Diagnosis

Abstract

Banana crop diseases threaten food security across the world, yet field diagnosis remains difficult because of limited expert access and visual similarity among disease classes. We present BananaVLM, a domain-adapted vision-language model for banana disease diagnosis built on LLaVA-v1.5-7B and fine-tuned with Low-Rank Adaptation (LoRA). To address the lack of multimodal agricultural instruction data, we introduce BananaInstruct, an automated pipeline that converts raw disease images into $\approx$80,000 question--answer pairs without manual annotation, using LLaVA-1.5-13B for symptom descriptions and Mistral-7B for agricultural Q&A generation and label grounding. Evaluated against 14 open-source and 5 closed-source VLMs on a nine-class benchmark, BananaVLM achieves 92.21% in-domain and 83.28% out-of-domain (OOD) classification accuracy, outperforming the best closed-source baseline, Gemini~2.5~Pro, by 49.8 and 63.3 percentage points, respectively. Binary healthy/diseased identification reaches 98.38% OOD accuracy with 1.00 recall. A controlled LoRA--DoRA comparison shows that DoRA performance degrades across epochs, while LoRA remains more effective for fine-grained classification. Qualitative evaluation using nine LLM judges yields G-Eval win rates of 0.81--0.96, while five domain experts prefer BananaVLM in 98.48% of 990 blind pairwise comparisons. These results show that lightweight domain adaptation with automated instruction tuning is an effective and scalable approach for specialized agricultural AI. Code, datasets, and model weights are available at https://github.com/samy101/banana-vlm

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sangam Kumar Jena, Pandarasamy Arjunan. 2026-08-27. BananaVLM: A Domain-Adapted Vision Language Model for Banana Crop Disease Diagnosis. https://arxiv.org/abs/2609.25040

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

An efficient and flexible generalization of transit compartment models for delayed biological processes

Transit compartment models are widely used in pharmacokinetics/pharmacodynamics to represent delayed biological processes such as absorption, maturation, cellular proliferation, and treatment-induced toxicity. This transit compartment formulation imposes an artificial relationship between the mean and variance of the delay distribution, as the number of transit compartment must be integer-valued number of transit compartments. Consequently, estimating the number of compartments from experimental data leads to mixed-integer optimization problems that artificially constrain model dynamics and bias parameter inference. However, these transit compartment models are mathematically equivalent to distributed delay differential equations with Erlang delay kernels. We leverage a hypoexponential generalization of these distributed delay differential equations that preserves the familiar ordinary differential equation structure while allowing the mean and variance of the delay distribution to be estimated directly as real-valued parameters. This approach does not increase the number of inferred parameters and can be immediately implemented as a straightforward modification of existing transit compartment models. We demonstrate the approach using models of viral eclipse phases, lymphocyte proliferation, and chemotherapy-induced neutropenia. Across these examples, the hypoexponential formulation provides comparable or improved fits relative to Erlang transit models and substantially reduces computational cost by avoiding grid search over compartment numbers. This framework provides a practical approach to estimate biologically meaningful delay distributions in quantitative systems pharmacology (QSP) models.

q-bio.QM↗

STAMP as a topology-aware molecular language for fragment-level learning and editing

Molecular fragments provide chemically meaningful units, but existing molecular languages rarely make their locations and connections explicit for editing. Here we introduce STAMP (Sequential Tree Attachment-based Motif-Preserving representation), a topology-aware molecular language that connects fragment-level representation learning with precise structural editing. STAMP separately encodes motif identity, attachment sites and tree topology, making fragments reusable across contexts and subtrees directly accessible. Learned representations capture motif similarity and recurring transformations, and lower activity-cliff prediction error on 23 of 30 targets versus a matched SMILES encoder. Compatible subtree operations support scaffold-preserving optimization, ranking first among six methods on 15 of 23 benchmark objectives. A deterministic compiler enables frozen language models to act on indexed fragments, improving molecular editing, optimization, transformation transfer and change identification by 9 to 56 percentage points over plain SMILES. Together, these results establish an executable molecular language in which learned chemical units remain directly operable during design.

q-bio.QM↗

Brain Age Gap Progression in Individuals at Risk for Neurodegeneration

Neuroimaging is a widely used modality for characterizing neurodegeneration in various health conditions. Brain age gap has emerged as a promising biomarker for monitoring brain health from neuroimaging data using machine learning algorithms. Recent studies have leveraged coVariance neural networks (VNN)-driven pipelines based on the advancements in graph signal processing for relatively transparent construction of brain age gap from neuroimaging data. In this paper, we focus on a longitudinal study of VNN-based brain age gap in conjunction with Alzheimer's Progression Score (APS) in individuals that are at a higher risk of neurodegeneration due to family history of Alzheimer's disease. APS is a multimodal marker of disease progression. The longitudinal analysis of APS and VNN-derived brain age gap metrics revealed that a higher risk of disease progression at baseline predicted a larger rate of increase in brain age gap in follow-up visits. Thus, our findings revealed potential stratification in the brain age gap modulated by clinical/biological risks of AD in the at-risk population.

q-bio.QM↗